Alpha-1-Proteinase Inhibitor
Records for this ingredient, by country (identity only).
ATC — · 1 markets · 9 records
AU 9 records · 6 shown of 6
- 1,000 mg per mL / per unit basis not statedliquidPROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vialZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial
- 4,000 mg per mL / per unit basis not statedliquidPROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial
- 500 mg per mL / per unit basis not statedliquidPROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial
- 5,000 mg per mL / per unit basis not statedinjectionZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial
- 4,000 mg per mL / per unit basis not statedinjectionZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial
- 1,000 mg per mL / per unit basis not statedinjectionCSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名PROLASTIN C LIQUID ×1Prolastin-C ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.